Edition:
United States

Adverum Biotechnologies Inc (ADVM.OQ)

ADVM.OQ on NASDAQ Stock Exchange Global Market

3.24USD
18 Jan 2019
Change (% chg)

$0.09 (+2.86%)
Prev Close
$3.15
Open
$3.15
Day's High
$3.32
Day's Low
$3.09
Volume
87,135
Avg. Vol
126,686
52-wk High
$8.55
52-wk Low
$2.62

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 0.83 -0.336
Jun '18 0.49 -0.302
Mar '18 0.22 -0.300
FY 2017 Dec '17 0.46 -0.100
Sep '17 0.46 -0.319
Jun '17 0.46 -0.266
Mar '17 0.46 -0.382
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 4 0.29 0.40 0.16 --
Quarter Ending Jun-19 4 0.29 0.40 0.16 --
Year Ending Dec-19 6 1.31 1.80 0.64 0.95
Earnings (per share)
Quarter Ending Mar-19 4 -0.28 -0.20 -0.33 --
Quarter Ending Jun-19 4 -0.27 -0.20 -0.30 --
Year Ending Dec-19 6 -1.14 -0.70 -1.48 -1.42
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 95.96 30.88
P/E High - Last 5 Yrs. -- 287.89 46.69
P/E Low - Last 5 Yrs. -- 90.15 25.78
Beta 3.88 0.66 0.95
Price to Sales (TTM) 111.11 242.95 21.76
Price to Book (MRQ) 1.03 18.87 4.53
Price to Tangible Book (MRQ) 1.03 22.13 11.76
Price to Cash Flow (TTM) -- 54.67 22.24
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 0.39 1.60
Dividend Yield - 5 Year Avg -- 0.20 1.42
Dividend 5 Year Growth Rate -- 3.31 -8.76
Payout Ratio(TTM) -- 6.79 44.03

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 79.91 156.34 6.54
Sales (TTM) vs TTM 1 Yr. Ago 6.77 61.53 5.26
Sales - 5 Yr. Growth Rate 128.01 24.06 7.59
EPS (MRQ) vs Qtr. 1 Yr. Ago -5.27 196.06 22.50
EPS (TTM) vs TTM 1 Yr. Ago 30.94 -- --
EPS - 5 Yr. Growth Rate -- 23.46 7.64
Capital Spending - 5 Yr. Growth Rate 220.59 37.07 8.38

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 3.57 2.63
Current Ratio (MRQ) 22.07 6.87 3.68
LT Debt to Equity (MRQ) 0.00 16.70 9.53
Total Debt to Equity (MRQ) 0.00 21.89 13.39
Interest Coverage (TTM) -- -289.65 33.85

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 31.33 50.91
Gross Margin - 5 Yr. Avg. -- 47.59 52.22
EBITD Margin (TTM) -3,497.35 -- --
EBITD - 5 Yr. Avg -2,739.61 -141.70 16.27
Operating Margin (TTM) -3,840.09 -1,638.83 -15.11
Operating Margin - 5 Yr. Avg. -3,770.56 -155.53 11.89
Pre-Tax Margin (TTM) -3,644.88 -1,574.14 -13.67
Pre-Tax Margin - 5 Yr. Avg. -3,727.37 -157.11 12.22
Net Profit Margin (TTM) -3,075.09 -1,572.92 -17.11
Net Profit Margin - 5 Yr. Avg. -3,563.51 -158.05 8.44
Effective Tax Rate (TTM) -- 15.93 21.73
Effective Tax Rate - 5 Yr. Avg. -- 19.64 24.41

Efficiency

  Company industry sector
Revenue/Employee (TTM) 25,679 28,103,806 878,349,382
Net Income/Employee (TTM) -789,667 -3,710,889 102,474,711
Receivable Turnover (TTM) -- 9.19 5.49
Inventory Turnover (TTM) -- 2.64 3.99
Asset Turnover (TTM) 0.01 0.46 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -29.05 0.35 11.06
Return on Assets - 5 Yr. Avg. -31.17 2.90 11.85
Return on Investment (TTM) -30.46 0.60 13.80
Return on Investment - 5 Yr. Avg. -32.40 2.87 15.17
Return on Equity (TTM) -31.07 -2.18 15.29
Return on Equity - 5 Yr. Avg. -34.45 -0.88 16.29
  1 Year 3 Year 5 Year
Sales % 27.08 47.86 128.01
EPS (TTM) % 66.44 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Adverum Biotechnologies Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -12.59 -12.58 47 99
13 Week -39.49 -34.63 40 94
26 Week -41.49 -41.32 54 96
52 Week 16.07 12.57 99 98
YTD 1.14 0.82 99 94
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 75.88%
# of Holders: 138
Total Shares Held: 47,707,571
3 Mo. Net Change: 1,679,956
# New Positions: 20
# Closed Positions: 17
# Increased Positions: 70
# Reduced Positions: 48
# Net Buyers: 22
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.